FFT Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-50
Closed -$5K – 105
2021
Q2
$5K Buy
+50
New +$4.25K ﹤0.01% 239

Other funds holding ARKG

FFT Wealth Management's ARKG Position: Q3 2021 in Review

FFT Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 50 shares — an estimated $5K sold.

FFT Wealth Management first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • FFT Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • FFT Wealth Management sold 50 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $5K.
  • FFT Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
  • FFT Wealth Management's ARK Genomic Revolution ETF position peaked at $5K in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on FFT Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.